Assessment of the ENI Gemeni Microprocessor-Controlled Centrifugal Analyser
Author Information
Author(s): N. Potezny, R.G. White, T.D. Geary
Primary Institution: Institute of Medical and Veterinary Science
Hypothesis
The ENI Gemeni is suitable as a general laboratory instrument.
Conclusion
The ENI Gemeni provides precise and accurate results for glucose, cholesterol, and alkaline phosphatase, but the results for calcium are unacceptable.
Supporting Evidence
- Intrabatch imprecision for glucose was found to be clinically acceptable despite being statistically significant.
- Cholesterol and alkaline phosphatase methodologies showed acceptable precision over the range of values assayed.
- The instrument's quality control factor and reagent drift printout aid in maintaining quality control.
- Results for glucose, cholesterol, and alkaline phosphatase were acceptable based on established criteria.
- Calcium methodology was found to be unacceptable in terms of accuracy.
Takeaway
The ENI Gemeni is a machine that helps test blood samples, and it works well for most tests but not for calcium.
Methodology
The assessment involved comparing the Gemeni's results with established methods for glucose, cholesterol, calcium, and alkaline phosphatase.
Potential Biases
Potential bias exists if the results are significantly different from comparative methods.
Limitations
The instrument lacks flexibility due to its fixed programming, making it difficult to use with kits from other manufacturers.
Statistical Information
P-Value
3.30 for glucose, 11.00 for cholesterol, 3.68 for calcium, 1.5 for alkaline phosphatase
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website